Product NDC: | 42023-131 |
Proprietary Name: | Colistimethate |
Non Proprietary Name: | colistimethate sodium |
Active Ingredient(s): | 150 mg/2mL & nbsp; colistimethate sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42023-131 |
Labeler Name: | JHP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050108 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20120601 |
Package NDC: | 42023-131-01 |
Package Description: | 1 VIAL in 1 CARTON (42023-131-01) > 2 mL in 1 VIAL |
NDC Code | 42023-131-01 |
Proprietary Name | Colistimethate |
Package Description | 1 VIAL in 1 CARTON (42023-131-01) > 2 mL in 1 VIAL |
Product NDC | 42023-131 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | colistimethate sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120601 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | JHP Pharmaceuticals, LLC |
Substance Name | COLISTIMETHATE SODIUM |
Strength Number | 150 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |